106047|t|Neurotoxicity with combined use of lithium and thioridazine.
106047|a|Four cases on a combination of lithium and thioridazine developed severe neurotoxic symptoms, e.g., delirium, seizures, encephalopathy and grossly abnormal EEG's. All patients had been on lithium without thioridazine prior to and after the neurotoxic episode with no complications or EEG changes. The possible risk of combining lithium and neuroleptics (thioridazine) is discussed and repeated EEGs are recommended as a preventive measure.
106047	0	13	Neurotoxicity	Disease	MESH:D020258
106047	35	42	lithium	Chemical	MESH:D008094
106047	47	59	thioridazine	Chemical	MESH:D013881
106047	92	99	lithium	Chemical	MESH:D008094
106047	104	116	thioridazine	Chemical	MESH:D013881
106047	134	153	neurotoxic symptoms	Disease	MESH:D020258
106047	161	169	delirium	Disease	MESH:D003693
106047	171	179	seizures	Disease	MESH:D012640
106047	181	195	encephalopathy	Disease	MESH:D001927
106047	228	236	patients	Species	9606
106047	249	256	lithium	Chemical	MESH:D008094
106047	265	277	thioridazine	Chemical	MESH:D013881
106047	301	311	neurotoxic	Disease	MESH:D020258
106047	389	396	lithium	Chemical	MESH:D008094
106047	415	427	thioridazine	Chemical	MESH:D013881
106047	Positive_Correlation	MESH:D008094	MESH:D012640
106047	Positive_Correlation	MESH:D013881	MESH:D012640
106047	Positive_Correlation	MESH:D008094	MESH:D001927
106047	Positive_Correlation	MESH:D008094	MESH:D020258
106047	Positive_Correlation	MESH:D013881	MESH:D001927
106047	Positive_Correlation	MESH:D008094	MESH:D003693
106047	Cotreatment	MESH:D008094	MESH:D013881
106047	Positive_Correlation	MESH:D013881	MESH:D020258
106047	Positive_Correlation	MESH:D013881	MESH:D003693

